For Novavax, the vaccine approval is only the beginning. The company has a lot working in its favor and the sky is the limit for NVAX stock. More
Articles
Is it Time to Invest in a Beaten-Up MicroVision’s Mega Vision?
Slow sales growth, persistent dilution, and heightened cash burn could weigh on MicroVision stock in 2022. Could a speculative buy on MVIS stock pay off next year? More
NAKD Stock Alert: Did Naked Brand Really Gain 1,000%+ Today? 8 Things to Know.
Many investors are confused after seeing popular financial sites report a 1,000% gain for NAKD stock. A reverse stock split is to blame. More
AVCT Stock: 7 Things to Know About Meme Penny Stock American Virtual Cloud Technologies as Shares Surge Today
American Virtual Cloud Technologies (AVCT) stock is taking off on Wednesday despite a lack of news and we're diving into the reasons why! More
The Pressure’s Mounting for Cardano to Perform in 2022
If stocks grind to a halt in 2022, investors better hope cryptocurrencies like Cardano deliver. The alternative scenario won’t be pretty. More
Evaluating Our Megatrends of 2021
At the beginning of the year, I identified three megatrends for 2021. Here's how those three trends played out over the course of the year. More
Twilio Is Selling at a Bargain Level for a Cloud Software Company
Twilio is selling at a bargain level for a cloud software company. Twilio may still be in growth mode, albeit at a lower level, putting TWLO stock at a bargain level here. More
